Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 126,279 | 114,270 | 106,257 | 94,845 | 77,468 |
| Cost of Goods | 35,996 | 19,798 | 14,678 | 7,020 | 4,169 |
| Gross Profit | 90,283 | 94,472 | 91,579 | 87,825 | 73,299 |
| Operating Expenses | 273,912 | 169,212 | 157,012 | 186,658 | 330,431 |
| Operating Income | -182,633 | -73,942 | -64,755 | -98,813 | -256,963 |
| Interest Expense | 14,085 | 25,747 | 19,327 | 17,881 | 13,431 |
| Other Income | 11,470 | -2,360 | 18,361 | 9,226 | 20,386 |
| Pre-tax Income | -185,248 | -102,049 | -65,721 | -107,468 | -250,008 |
| Income Tax | -137 | -163 | 169 | N/A | N/A |
| Net Income Continuous | -185,111 | -101,886 | -65,890 | -107,468 | -250,008 |
| Net Income | $-185,111 | $-101,886 | $-65,890 | $-107,468 | $-250,008 |
| EPS Basic Total Ops | -32.23 | -19.49 | -17.69 | -29.09 | -70.61 |
| EPS Basic Continuous Ops | -32.30 | -19.47 | -17.70 | -29.15 | -70.54 |
| EPS Diluted Total Ops | -32.23 | -19.49 | -17.69 | -29.09 | -70.61 |
| EPS Diluted Continuous Ops | -32.30 | -19.47 | -17.70 | -29.15 | -70.54 |
| EBITDA(a) | $-158,256 | $-55,931 | $-46,338 | $-79,844 | $-216,578 |